Immune Response to Vaccination in Patients with Psoriasis Treated with Systemic Therapies
Psoriasis is a chronic inflammatory skin disease usually treated with immunomodulatory/immunosuppressive agents. The use of these agents has been associated with an increased susceptibility to infections. Vaccination might represent a critical aspect in the management of patients with psoriasis trea...
Main Authors: | Andrea Chiricozzi, Paolo Gisondi, Francesco Bellinato, Giampiero Girolomoni |
---|---|
Format: | Article |
Language: | English |
Published: |
MDPI AG
2020-12-01
|
Series: | Vaccines |
Subjects: | |
Online Access: | https://www.mdpi.com/2076-393X/8/4/769 |
Similar Items
-
SYSTEM THERAPY OF PSORIASIS IN CHILDREN (PART I)
by: L. S. Namazova-Baranova, et al.
Published: (2017-10-01) -
The Risk of COVID-19 Pandemic in Patients with Moderate to Severe Plaque Psoriasis Receiving Systemic Treatments
by: Paolo Gisondi, et al.
Published: (2020-12-01) -
The Effect of Systemic Methotrexate and Cyclosporine Combination Therapy inPsoriasis Vulgaris Patients in Bandung, Indonesia
by: Oki Suwarsa, et al.
Published: (2021-11-01) -
Clinical Characteristics of Patients with Pustular Psoriasis: A Single-Center Retrospective Observational Study
by: Paolo Gisondi, et al.
Published: (2022-07-01) -
Central Pain Sensitization in Patients with Chronic Plaque Psoriasis
by: Francesco Bellinato, et al.
Published: (2023-03-01)